米鲁姆制药 MIRM
$93.72 +$0.18 (+0.19%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $93.72 0.00%
开盘$93.14
昨收$93.54
当日区间$91.18 – $95.68
成交量722.7K
市值$6.12B
市盈率（TTM）–
股息率–
MIRM 相关新闻
匹配 Mirum Pharmaceuticals 或代码 MIRM 的头条新闻，按最新排序。
- Baird Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $130 正面
- H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $195
- Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $160
- A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $130 to $195
- J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating
- Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Mirum Pharmaceuticals (MIRM) 正面
- Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $145
- A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $118 to $140
- J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Cuts Target Price to $118 负面
- A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $135 to $140
- H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $185
- H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $140
- J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $118
- J.P. Morgan Keeps Their Buy Rating on Mirum Pharmaceuticals (MIRM)
- TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $140
暂无评论——快来第一个聊聊 MIRM。